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Abstract
We have recently identified the membranotropic regions of the hepatitis C virus proteins E1, E2, core and p7 proteins by
observing the effect of protein-derived peptide libraries on model membrane integrity. We have studied in this work the
ability of selected sequences of these proteins to modulate the Lb-La and La-HII phospholipid phase transitions as well as
check the viability of using both DSC and SAXD to screen a protein-derived peptide library. We demonstrate that it is
feasible to screen a library of peptides corresponding to one or several proteins by both SAXD and DSC. This
methodological combination should allow the identification of essential regions of membrane-interacting proteins which
might be implicated in the molecular mechanism of membrane fusion and/or budding.
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Introduction
Hepatitis C virus (HCV), an enveloped positive single-stranded
RNA virus, is an important public health problem since it is the
leading cause of acute and chronic liver disease in humans,
including chronic hepatitis, cirrhosis, and hepatocellular carcino-
ma [1,2,3]. Currently, there is not vaccine to prevent the HCV
infection and the available therapeutic agents, apart from being
associated to different adverse effects, have very limited efficacy
against the virus [4]. HCV entry into the host cell is achieved by
fusion of the viral and cellular membranes, and morphogenesis
and virion budding has been suggested to take place in the
endoplasmic reticulum [5]. The HCV genome is widely
heterogeneous, and replication errors cause a high rate of
mutations [6]. The variability of the HCV proteins gives the virus
the ability to escape the host immune surveillance system and
notably hampers the development of an efficient vaccine. Thus,
finding inhibitors of protein-membrane and protein-protein
interactions involved in virus fusion and/or budding could be an
alternative and valuable strategy against HCV infection since they
could be potential therapeutic agents.
The HCV genome consists of one translational open reading
frame encoding a polyprotein precursor, including structural and
non-structural proteins, that is cleaved by host and viral proteases
(Figure 1A). The structural proteins include the protein core,
which forms the viral nucleocapsid, and the envelope glycopro-
teins E1 and E2, both of them transmembrane proteins. The
structural proteins are separated from the non-structural proteins
by the short membrane protein p7. The core protein is highly
basic and shows homology with the nucleocapsid protein of other
flaviviruses. This protein is well conserved among the different
HCV strains [7] and has regulatory roles on cell functions like
immune presentation, apoptosis, lipid metabolism and transcrip-
tion [8,9,10]. Recombinant cDNA expression studies of this
protein have identified two major protein core species, p23 and
p21, being the later the predominant species [9]. Significantly, the
mature core protein is a dimeric a-helical protein exhibiting
membrane protein features [11]. The two envelope glycoproteins,
E1 and E2, are anchored to the host cell-derived double-layer lipid
envelope. E1 and E2 are essential for entry, binding to receptors
and inducing fusion with the host-cell membrane as well as in viral
particle assembly [12]. E1 and E2 are type-I transmembrane (TM)
glycoproteins, with N-terminal ectodomains and a short C-
terminal TM domain. These proteins interact with each other
and assemble as non-covalent heterodimers and their TMs play a
major role in heterodimer formation, membrane anchoring and
endoplasmic reticulum retention [13]. E1 and E2 are thought to
be class II fusion proteins because the putative fusion peptide is
supposedly localized in an internal sequence linked by antiparallel
b-sheets [14]. Protein p7 is classified neither as structural protein
nor as non-structural, locates in the cell ER and has been
described to be a viroporin-like protein [15,16,17,18]. p7 is
essential for efficient assembly and release of infectious virions
indicating that p7 is primarily involved in the late phase of the
virus replication cycle [17]. At a molecular level, p7 is a small
transmembrane protein with two transmembrane helical domains
connected by a loop [19,20]. One possible role for this protein
could be the transport of ions from the ER to the cytoplasm of
HCV-infected host cells, suggesting that p7 could be a attractive
candidate for antiviral drug development.
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HCV E1, E2, core and p7 proteins by observing the effect of protein-
derived peptide libraries on model membrane integrity [21,22,23].
These results have permitted us to suggest the possible location of
different segments in these proteins which might be implicated in
protein-lipid and protein-protein interactions, helping us to under-
stand the mechanisms underlying the interaction between viral
proteins and membranes. Moreover, it has been found a good
correlation between the ability of different peptides to affect the
lamellar to hexagonal phase transition (LaRHII)o fs y n t h e t i c
membranes with membrane perturbation and/or fusogenic activity
[24]. Therefore we have selected different peptides from the HCV
proteins E1, E2, core and p7 showing different membrano-active
properties in order to screen and examine their effect on the
polymorphic phase behavior of 1,2-dielaidoyl-sn-glycero-3-phospha-
tidylethanolamine (DEPE) by using differential scanning calorimetry
(DSC) and small angle X-ray diffraction (SAXD).
Results
The peptides used in this study and their correlation with the
HCV proteins core, E1, E2 and p7 are shown in Figure 1. In our
previous works [21,22,23], we examined the membranotropic
activity of a series of peptide libraries pertaining to the full
sequences of the core, E1, E2 and p7 proteins in order to detect
their membranotropic regions. It is known that not all of the
membrano-active segments of membrane fusion proteins might
have a direct membrane role, i.e., membrane fusion [25]. Because
of that, we have selected different peptides from the aforemen-
tioned peptide libraries in order to check their ability to modulate
the polymorphism in DEPE vesicles. The peptides chosen
pertained to sequences 29–46, 57–74, 85–102, 113–120 and
155–172 from the core protein, sequences 197–214, 260–277,
281–298, 316–333 and 351–368 from the E1 protein, sequences
400–417, 435–452, 547–564, 617–634 and 708–725 from the E2
protein and sequences 750–767, 771–788, and 785–802 from the
p7 protein (see Table 1). As observed in Figure 1, several of these
peptides belong to regions showing high membranotropic
activities.
In order to examine the effect on these peptides on the Lb/La/
HII phase transitions of DEPE and obtain Information on the
structural organization of the DEPE/peptide systems, we have
used both DSC and SAXD [26,27]. SAXD not only defines the
macroscopic phase-structure of the phospholipid bilayer, but also
Figure 1. Scheme of the HCV polyprotein according to literature consensus, including the structural and non-structural proteins.
The sequence and relative location of the 18-mer peptides used in this work, derived from the HCV core, E1, E2 and p7 proteins, are shown with
respect to the sequence of the polyprotein. A summary of the normalized experimental membrane rupture data corresponding to 18-mer peptide
libraries derived from the whole HCV core [22], E1 [23], E2 [23] and p7 [21] proteins is also shown (the darker, the higher).
doi:10.1371/journal.pone.0004356.g001
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the 2D-hexagonal unit cell dimensions in the hexagonal phase.
Aqueous dispersions of pure DEPE undergo a gel to liquid-
crystalline (LbRLa) phase transition in the lamellar phase at about
37uC and in addition a lamellar liquid-crystalline to hexagonal-HII
(LaRHII) phase transition at about 65uC [28]. Figure 2A shows
the diffraction patterns corresponding to pure DEPE at different
temperatures. Lipids organized in multilamellar structures are
expected to give rise to reflections with distances which relate as
1:1/2:1/3 [29]. The largest first-order reflection component
corresponds to the inter-lamellar repeat distance, which is
comprised of the bilayer thickness and the thickness of the water
layer between bilayers. Pure DEPE in the lamellar gel state at
25uC showed a characteristic first-order reflection with an inter-
lamellar repeat distance of about 65 A ˚. As it has been previously
observed in DEPE systems in the lamellar state, some higher-order
reflections were not found [30]. At 45uC, pure DEPE in the fluid
lamellar state showed a first-order reflection with an inter-lamellar
repeat distance of about 54 A ˚, showing a decrease in the first-
order repeat distance of about 10 A ˚, due to the decrease of the
effective acyl chain length. Lipids organized in the hexagonal HII
phase give rise to reflections which relate as 1:1/!3:1/!4:1/!7
[29]. In our case, pure DEPE in the hexagonal HII phase at 70uC
clearly showed the reflections characteristic of this phase, the first
one at about 66 A ˚, as observed in Figure 2A. By DSC, pure DEPE
presented a highly cooperative endothermic gel to liquid-
crystalline phase transition Tm (temperature of the gel-to–liquid
crystalline phase transition) at 37.8uC and a lamellar-to-inverted
hexagonal HII transition at 64.3uC as shown in Figure 2F.
Therefore, by using both DSC and SAXD we are able of
characterizing the phase polymorphism of DEPE in the presence
of the chosen peptides.
Recently, we have found that the HCV core protein presents
several membranotropic regions which might play an important
role in its biological action, specifically on the budding process
[22]. We have chosen different peptides pertaining to these
membranotropic regions and studied their modulatory effect on
DEPE membranes as shown in Figure 2 (sequences 29–46, 57–74,
85–102, 113–120 and 155–172). As observed in Figure 2A, the
peptide corresponding to sequence 29–46 from the HCV core
protein did not show any effect on the DEPE SAXD reflections at
both 25uC and 45uC. However, at 70uC, the presence of a broad
SAXD signal indicates the presence of uncorrelated membranes,
[31] and at the same time accompanied by small reflections
corresponding to the HII phase. DSC indicates that the peptide
decreases slightly the enthalpy of the main transition with a
concomitant broadening (Figure 2F). However, it decreased
significantly the enthalpy and the transition temperature of the
lamellar to hexagonal phase transition of the phospholipid (from
64.2uC to 56.3uC) (Figure 2F). Peptide 57–74 did not give rise to
any different SAXD reflections, showing that its interaction with
the membrane did not have any significant changes in the
membrane structure of DEPE (Figure 2B). By DSC, a small
decrease in TH was observed from 64.2uC to 61.4uC (Figure 2G).
The GAP analysis of the effect produced by the peptide
corresponding to sequence 85–102 shows that at 25uC the
membrane thickness is slightly decreased but increased at 45uC
(Figure 2C). Interestingly, at 70uC it is observed that there is a
coexistence of lamellar and hexagonal phases (Figure 2C).
Similarly to what was found with peptide 29–46, DSC shows that
sequence 85–102 decreases slightly the enthalpy of the main
transition as well as decreases the enthalpy and temperature of the
TH transition from 64.2uC to 62.1uC, broadening it (Figure 2H).
Peptide 113–120 did not give rise to any different SAXD
Table 1. Sequence and numbering of the peptides from the HCV proteins core, E1, E2 and p7 used in this work, as well as a
summary of the experimental data.






CORE 29–46 QIVGGVYLLPRRGPRLGV 2 ++ + +
57–74 QPRGRRQPIPKARRPEGR + 22 +
85–102 LYGNEGLGWAGWLLSPRG +++ + 2 ++
113–130 RRRSRNLGKVIDTLTCGF +++ 22 2
155–172 VRVLEDGVNYATGNLPGC 22 2 +++
E1 197–214 VSGIYHVTNDCSNSSIVY 22 2 +
260–277 RHVDLLVGTAAFCSAMYV + 22 +
274–298 AMYVGDLCGSIFLVSQLF + +++ 2 ++
316–333 HRMAWDMMMNWSPTTALV + + + +++
351–368 AHWGVLAGLAYYSMVGNW ++ 2 +
E2 400–417 TSLFSSGASQKIQLVNTN ++ 2 +
435–452 TGFFAALFYAHKFNSSGC ++ 2 +
547–564 GNWFGCTWMNSTGFTKTC ++ 2 +
617–634 LTPRCLVDYPYRLWHYPC +++ +++ + +++
708–705 AFVSFAIKWEYILLLFLL + 22 +
P7 750–767 NLVVLNAASVAGAHGILS 22 2 2
771–788 FFCAAWYIKGRLAPGAAY +++ 22 2
785–802 GAAYAFYGVWPLLLLLLA + 22 2
1(2), 0–15%, 15%.(+).50%, 50%.(+++).100% [21,22,23].
*(+), DTHII between 0 and 5uC, (++) DTHII greater than 5uC, (+++)N oH II phase (this work).
doi:10.1371/journal.pone.0004356.t001
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have any significant changes in the membrane structure of DEPE
(Figure 2D). However, it decreases the membrane thickness at
45uC. DSC shows that the peptide decreases slightly the enthalpy
of both DEPE transitions, the gel –to-liquid-crystalline transition
and the lamellar-to-hexagonal phase transition, without a
significant change in the transition temperatures (Figure 2I). In
contrast to what was observed above, peptide 155–172 induced
significant changes in the SAXD pattern of DEPE (Figure 2E).
Whereas at 25uC and 45uC there were no significant differences
with pure DEPE, but a small increase in membrane thickness at
25uC; at 70uC there was no signal corresponding to the hexagonal
phase (Figure 2E). These results were corroborated by DSC, since
the peptide, apart from decreasing the enthalpy of the main
transition of the phospholipid, abolished completely the appear-
ance of the hexagonal phase transition endotherm (Figure 2J).
Similarly to what was found with the HCV core protein, we
previously found that the HCV E1 and E2 proteins present several
membranotropic regions [23]. Being E1 and E2 the proteins
which are responsible of the entry of the HCV virus into the target
cell, these membranotropic regions play an essential role in the
biological action of these proteins. The peptides we have chosen to
study their effect on DEPE are the peptides corresponding to
amino acid sequences 197–214, 260–277, 281–298, 316–333 and
351–368 from the E1 protein, and 400–417, 435–452, 547–564,
617–634 and 708–725 from the E2 protein (see Figure 3).
Peptides 197–214 and 260–277 from E1 did not give rise to any
significant differences in DEPE SAXD reflections, showing that its
interaction with the membrane did not induce any significant
changes in the membrane structure of DEPE (Figures 3A and 3B).
DSC shows that the peptides decreased only slightly the enthalpy
of both LbRLa and LaRHII transitions of DEPE, decreasing the
transition temperature of the La-HII phase transition from about
64.2uC to 61.1–61.4uC (Figures 2F and 2G). The peptide
corresponding to sequence 281–298 of the E1 protein decreases
the membrane thickness at both 25uC and 45uC but no significant
differences were found at 70uC when compared with the pure
phospholipid (Figure 3C). Interestingly, DSC shows the existence
of a slight decrease in the enthalpy of both transitions of DEPE but
a significant decrease in the La-HII transition temperature from
64.2uC to 55.64uC (Figure 2H). Significantly, peptide correspond-
ing to sequence 316–333 from HCV E1 induced a disordering
(presence of uncorrelated membranes) on DEPE at all studied
temperatures, as seen by SAXD (Figure 3D). Although there is an
increase in the membrane thickness, the reflections pertaining to
the different DEPE phases are recognized (Figure 3D). As
observed by DSC, the peptide induced the disappearance of the
La-HII transition as well as it induced the appearance of another
peak at about 41.51uC (Figure 3I). Similarly to peptides 197–214
and 260–277, peptide 351–368 did not give rise to any significant
differences in the DEPE SAXD reflections (Figure 3E). As
observed by DSC, the peptides decreased only slightly the
enthalpy of both DEPE transitions, decreasing the phase transition
temperature of the La-HII transition from 64.2uC to 61.1uC
(Figure 2J).
Peptides 400–417, 435–452 and 547–564 from the HCV E2
protein did not give rise to any significant differences in the DEPE
SAXD reflections, showing that its interaction with the membrane
did not have any significant changes in the membrane structure of
DEPE (Figures 4A, 4B and 4C). As observed by DSC, the peptides
induced a slight decrease in the enthalpy and temperature of the
La-HII transition (from 64.2uC to 62.5, 59.5 and 62.6uC,
respectively) (Figures 4F, 4G and 4I). In contrast to these peptides,
the peptide corresponding to sequence 617–634 of E2 induced a
disordering on the DEPE membranes at all studied temperatures
(presence of uncorrelated membranes), as observed by SAXD
(Figure 4D). There is an increase in the membrane thickness at all
temperatures and the reflections pertaining to the HII phase of
DEPE are not observed at 70uC (Figure 4D). As observed by DSC,
the peptide induced the disappearance of the La-HII endotherm
(Figure 4H). Peptide 708–725 did not give rise to any significant
differences in the DEPE SAXD reflections (except for a decrease
Figure 2. (A–E) Small angle X-ray scattering at 25uC, 45uC and 70uC and (F–J) DSC heating thermograms of DEPE in the absence (——) and in the
presence (----) of the 18-mer peptides derived from the HCV core protein. The 18-mer peptides correspond to amino acid sequences 29–46 (A,F), 57–
74 (B,G), 85–102 (C,H), 113–120 (D,I) and 155–172 (E,J). The peptide/phospholipid molar ratio was 1:50 in all cases.
doi:10.1371/journal.pone.0004356.g002
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peptide did not induce any significant changes in the DEPE main
transition but a slight decrease in the temperature of the La-HII
transition (from 64.2uC to 62.6uC) (Figure 4J).
We have recently identified that the HCV p7 protein presents a
highly membranotropic region coincidental with the loop region
[21]. However, this membranotropic region is not related to any
effect on the phase polymorphism of the membrane, but to its
action as a viroporin-like protein [21]. We have studied three
peptides from p7 with DEPE membranes; these sequences were
750–767, 771–788, and 785–802 (Figure 5). As observed in
Figure 5, peptides pertaining to sequences750–767, 771–788, and
Figure 3. (A–E) Small angle X-ray scattering at 25uC, 45uC and 70uC and (F–J) DSC heating thermograms of DEPE in the absence (——) and in the
presence (----) of the 18-mer peptides derived from the HCV E1 protein. The 18-mer peptides correspond to amino acid sequences 197–214 (A,F),
260–277 (B,G), 281–298 (C,H), 316–333 (D,I) and 351–368 (E,J). The peptide/phospholipid molar ratio was 1:50 in all cases.
doi:10.1371/journal.pone.0004356.g003
Figure 4. (A–E) Small angle X-ray scattering at 25uC, 45uC and 70uC and (F–J) DSC heating thermograms of DEPE in the absence (——) and in the
presence (----) of the 18-mer peptides derived from the HCV E2 protein. The 18-mer peptides correspond to amino acid sequences 400–417 (A,F),
435–452 (B,G), 547–564 (C,H), 617–634 (D,I) and 708–725 (E,J). The peptide/phospholipid molar ratio was 1:50 in all cases.
doi:10.1371/journal.pone.0004356.g004
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DEPE SAXD reflections, showing that its interaction with the
membrane did not have any significant changes in the membrane
structure of DEPE (Figures 5A, 5B and 5C). Interestingly, all
peptides are able of decreasing the enthalpy of both DEPE
transitions, the Lb-La and La-HII transitions, as well as increasing
the La-HII phase transition temperature (from 64.2uC to about
66.1–67.1, 65.3 and 65.7uC, respectively) (Figures 5D, 5E and 5F).
Interestingly, peptide pertaining to sequence 750–767 is capable of
inducing a broad La-HII phase transition which seems to have two
different transitions (Figure 5D).
Discussion
Envelope fusion glycoproteins located on the outer surface of the
viral membranes mediate the fusion of the viral and cellular
membranes [32,33]. The three-dimensional structure of class I and
class II membrane fusion proteins is different but their function is
identical, sotheymustsharestructuralandfunctionalcharacteristics
in specific domains which interact with and disrupt biological
membranes [32,33]. Additionally, different membrane binding
regions from membrane fusion proteins are necessary to complete
the fusion process [34]. In general, fusion implies the insertion of
specific regions that disrupt the membrane, leading to the formation
of a initial local lipid connection (lipid stalk) [35,36]. This lipid stalk
is then believed to expand into a hemifusion diaphragm whose
rupture would finally generate a fusion pore [35,36]. Membrane
fusion does not necessarily occur at the plasma membrane level;
viralentrycanalsoinvolveendocytosisandvesiculartrafficking,asit
happens in the case of HCV. Moreover, one of the most significant
points in the HCV viral cycle is the formation of a replication
complex, composed of the viral proteins, RNA and altered
membranes in infected hepatocytes forming the so called membra-
neous web [37,38]. Since we have shown previously the existence of
membranotropic regions of the HCV core, E1, E2 and p7 proteins
[21,22,23], in this work we have made a specific screening for
studying the ability of selected sequences of these proteins to
modulate the well known Lb-La and La-HII transitions of DEPE
[28], with the objectives of checking a) the correlation of their
activity with the propensity to modulate the polymorphic phase
behavior of DEPE and b) the feasibility of using both DSC and
SAXD to screen the effect of a series of peptide libraries on the
polymorphic phase behavior of DEPE [25].
Protein sequences might have hydrophobic regions which form
the hydrofobic core needed for protein folding. Peptides originated
from these regions might interact with membranes and show
membrane leakage. However, membrane perturbation by itself is
not sufficient to complete the process of viral and cellular
Figure 5. (A–C) Small angle X-ray scattering at 25uC, 45uC and 70uC and (D–F) DSC heating thermograms of DEPE in the absence (——) and in the
presence (----) of the 18-mer peptides derived from the HCV E2 protein. The 18-mer peptides correspond to amino acid sequences 750–767 (A,D),
771–788 (B,E), 785–802 (C,F). The peptide/phospholipid molar ratio was 1:50 in all cases.
doi:10.1371/journal.pone.0004356.g005
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fusion is larger than for leakage (pore formation). Fusion peptides
show generally a high membrane-perturbing and fusogenic
activity, i.e., mixing membrane lipids and aqueous contents of
the vesicles (low leakage and high fusion values). However, there is
not a strict quantitative criterion for the degree of membrane
destabilization expected for a fusion peptide. On the other hand a
common property of fusion peptides is the tendency to promote
negative curvatures in the membrane. For this reason fusion
peptides tend to lower the bilayer to hexagonal phase transition
temperature of phosphatidylethanolamines. In principle only
peptides which present a significant effect on the polymorphic
phase behavior of DEPE could be located in regions implicated in
a stabilization/destabilization role of lamellar/non-lamellar struc-
tures, roles needed for fusion and budding.
Of the different peptides studied in this work, only peptides
corresponding to sequences 29–46 (core), 316–333 (E1) and 617–
634 (E2) gave rise to positionally uncorrelated membranes at high
temperatures. All these peptides affected significatively the La-HII
phase transition of DEPE as well as they presented a significant
effect on membrane fusion (Table 1). Apart from these peptides,
other peptides which presented a significant effect on the La-HII
phase transition of DEPE, were found to induce both membrane
fusion and leakage (Table 1). Interestingly, peptide 155–172
pertaining to the core protein, which did not show any significant
effect on both membrane rupture and fusion, affected significantly
the hexagonal transition of DEPE. This anomalous behavior
might be due to the fact that this peptide overlaps with part of the
signal sequence of the E1 protein.
Another important event in viral life is morphogenesis. This step
involves lipid membranes and it is not as well characterized as the
fusion event. For enveloped viruses, the assembly of the virions
takes place in the host cell membrane. In the case of HCV it has
been suggested that the assembly of the virus particles occurs in the
endoplasmic reticulum membranes where the core protein might
play a central role in viral particle formation as well as it might
drive the budding process [39]. Significantly, the HCV core
protein is very well conserved among different HCV strains and
has important regulatory roles on different cell functions. Peptide
29–46 corresponding to the core protein presents a significant
effect on DEPE polymorphism and therefore could be implicated
in the stabilization of non-lamellar structures needed for the
budding process. E1 and E2 envelope proteins induce the fusion
between the viral envelope and the host cell membrane. As
observed in Table 1, peptides 316–333 from E1 and 617–634 from
E2 affect significantly the polymorphic phase behavior of DEPE,
induce the presence of uncorrelated membranes, and present a
high effect of membrane rupture and fusion. As suggested
previously, the regions were these two peptides reside could hold
a similar function in the corresponding proteins as that observed
for other ones (i.e., gp41). Protein p7 is classified neither as a
structural nor as a non-structural protein, is located in the cell ER,
and forms a membrane pore. We have recently shown the
presence of a highly membranotropic region in p7 presenting high
leakage but low fusion (sequence 771–788). As shown in Table 1,
neither this sequence nor the other two sequences derived from p7
studied here present any significant effect on the polymorphic
phase behavior of DEPE. This data would suggest that p7,
although having a high membranotropic region, would be
implicated neither in membrane fusion nor in budding.
In conclusion, we have demonstrated that is feasible to screen a
library of peptides corresponding to one or several proteins by
both SAXD and DSC, or preferably by a simultaneous
combination of the two [31]. This methodology should allow the
identification of those peptides which lead to the loss of lipid
multilayer correlation as well as the modulation of the La-HII
phase transition, to correlate the data with experimentally
determined membrane rupture and fusion, and most important,
the identification of important regions of membrane-interacting
proteins which might be implicated in the molecular mechanism of




was purchased from Avanti Polar Lipids (Alabaster, AL, USA).
18-mer peptides derived from the core protein (5 peptides), the E1
envelope glycoprotein (6 peptides), the E2 envelope glycoprotein (5
peptides) and the p7 protein (3 peptides) from hepatitis C virus
strains 1B4J were obtained through the NIH AIDS Research and
Reference Reagent Program (Division of AIDS, NIAID, NIH,
Bethesda, MD). All other reagents used were of analytical grade
from Sigma-Aldrich (Madrid, ES, EU). Water was deonized, twice
distilled, and passed through Milli-Q equipment (Millipore
Iberica, Madrid, ES, EU) to a resistivity better than 18 MV cm.
Sample Preparation
Aliquots containing the appropriate amount of lipid in
chloroform/methanol (2:1 v/v) were placed in a test tube
containing the lyophilized peptide, mixed and the solvents
removed by evaporation under a stream of O2-free nitrogen.
Finally traces of solvents were eliminated under vacuum in the
dark over night. To obtain multilamellar vesicles, 200 ml of buffer
containing 20 mM HEPES, 50 mM NaCl at pH 7.4 was added to
the dry mixture. Afterwards, the samples were incubated at 45uC
(below the temperature of the lamellar liquid-crystalline to
hexagonal-HII transition of pure DEPE), with intermittent
vortexing for 30 min to hydrate the samples and obtain multi-
lamellar vesicles (MLV), followed by three freeze–thaw cycles to
ensure complete homogenization and maximization of peptide/
lipid contacts with occasional vortexing at 45uC. The total lipid
concentration was 67 mM for x-ray measurements and 26 mM for
DSC. The phospholipid and peptide concentration were measured
by methods described previously [40,41].
Small-angle X-ray scattering experiments
MLVs at a concentration of 5% (w/w) prepared without or with
the peptide at a lipid/peptide molar ratio of 50:1 were prepared as
stated above and submitted to 15 temperature cycles (heating at
45uC and cooling at 220uC). Small angle X-ray diffracction
(SAXD) measurements were carried out using a Hecus SWAX-
camera (System3,Hecus X-ray Systems, Graz, Austria) as described
previously [42] using Ni-filtered Cu-Ka radiation (l=1,54 A ˚)
originating from a sealed tube X-ray generator (GE-Seifert,
Ahrensburg, Germany) operating at a power of 2 kW (50 kV,
40 mA). Sample-to-detector distance was 27.8 cm. A linear-
position-sensitive detector was used with 1024-channel resolution.
SAXD angle calibration was done with silver stearate. The
measurements were performed with the sample placed in a thin-
walled 1-mm diameter quartz capillary held in a steel cuvette holder
at different temperatures with an exposure time of 1 h. The SAXD
curves were analyzed after background subtraction and normaliza-
tion in terms of a full q-range model using the program GAP [31].
Differential scanning calorimetry
MLVs were formed as stated above in 100 mM NaCl, 0.05 mM
EDTA and 25 mM HEPES, pH 7.4. The peptides were added to
Peptide Screening by DSC/SAXD
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was incubated at 45uC for one hour with occasional vortexing and
then centrifuged. The pellets containing lipid vesicles were
transferred to 50 ml DSC aluminium pans and hermetically
sealed. DSC experiments were performed in a Perkin Elmer Pyris
6 differential scanning calorimeter (Perkin-Elmer Instruments,
Shelton, USA) under a constant external pressure of 30 psi in
order to avoid bubble formation, and samples were heated at a
constant scan rate of 1.5uC/min. In order to avoid artefacts and
ensure scan-to-scan reproducibility due to the thermal history of
the sample, the first scan was never considered; second and further
scans were carried out until a reproducible and reversible pattern
was obtained. The last scan was used for calculations. After the
thermal measurements, the phospholipid content of the samples
was determined. Data acquisition was performed using the Pyris
Software for Thermal Analysis, version 4.0 (Perkin-Elmer
Instruments LLC) and Microcal Origin 7.0 software (Microcal
Software Inc., Northampton, MA, USA) was used for data
analysis. The thermograms were defined by the onset and
completion temperatures of the transition peaks obtained from
heating scans. The phase transition temperature was defined as the
temperature at the peak maximum.
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